Page last updated: 2024-10-28

hexamethonium and Shock

hexamethonium has been researched along with Shock in 2 studies

Hexamethonium: A nicotinic cholinergic antagonist often referred to as the prototypical ganglionic blocker. It is poorly absorbed from the gastrointestinal tract and does not cross the blood-brain barrier. It has been used for a variety of therapeutic purposes including hypertension but, like the other ganglionic blockers, it has been replaced by more specific drugs for most purposes, although it is widely used a research tool.

Shock: A pathological condition manifested by failure to perfuse or oxygenate vital organs.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
HRENOFF, AK1
SPOEREL, WE1

Other Studies

2 other studies available for hexamethonium and Shock

ArticleYear
Hexamethonium contributing to fatal shock in hypertensive epistaxis.
    California medicine, 1954, Volume: 81, Issue:6

    Topics: Cardiovascular Agents; Epistaxis; Hexamethonium; Hypertension; Muscle Relaxants, Central; Shock

1954
Observations on the action of hexamethonium bromide in tourniquet shock in rats.
    Canadian journal of biochemistry and physiology, 1955, Volume: 33, Issue:5

    Topics: Animals; Hexamethonium; Muscle Relaxants, Central; Rats; Shock; Tourniquets

1955